Menu

CONGRESS 2023 - Ovarian hyperstimulation syndrome (OHSS) – how does the clinical biochemistry laboratory inform clinical decisions?

Ovarian Hyperstimulation Syndrome is one of the most dangerous complications associated with assisted conception using invitro fertilisation (IVF). If not managed appropriately it can even lead to death of the women developing ovarian hyperstimulation syndrome. Clinical Biochemistry aids significantly in the diagnosis and management of ovarian hyperstimulation syndrome. This presentation aims to summarise the role of various biochemical parameters that are used routinely in the diagnosis and management of ovarian hyperstimulation syndrome.

Download as vCalendar (for Microsoft Outlook etc.)

Import event to your Google Calendar

27th September 2023
Venue: The International Convention Centre (ICC), Birmingham
Learning outcomes

This presentation will give:

  • An overview of Ovarian hyper stimulation syndrome and how measurement of relevant analytes in the Clinical Biochemistry department enable clinicians to assess risk factors, diagnose and monitor those who experience this disorder.